Table 3.
Patients with Peyronie’s disease who were candidates for collagenase clostridium histolyticum treatment in the University of Miami Hospital, Department of Male Reproductive Medicine, in the period November 2018-December 2019.
Candidates for Collagenase Clostridium Histolyticum | |||
---|---|---|---|
Noncalcified | Calcified | p | |
N (%) | 26 (28.3) | 66 (71. 7) | |
Curvature (degrees) | 46.1 ± 14.7 | 51.2 ± 17.6 | 0.17 |
Duration of symptoms | |||
(months) | 39.5 ± 61.2 | 22.6 ± 30.3 | 0.34 |